ITGA2 and hepatocellular carcinoma: Future studies will focus on elucidating the upstream regulatory mechanisms of ITGA2 in lenvatinib resistance in hepatocellular carcinoma and its crosstalk with other resistance-related pathways, thereby systematically clarifying the comprehensive regulatory network of ITGA2 in lenvatinib resistance.